- Home
- TVRD vs LPTH Comparison
TVRD vs LPTH Comparison
Compare TVRD & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- LPTH
- Stock Information
- Founded
- TVRD 2017
- LPTH 1985
- Country
- TVRD United States
- LPTH United States
- Employees
- TVRD N/A
- LPTH N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- LPTH Semiconductors
- Sector
- TVRD Health Care
- LPTH Technology
- Exchange
- TVRD Nasdaq
- LPTH Nasdaq
- Market Cap
- TVRD 246.5M
- LPTH 229.5M
- IPO Year
- TVRD N/A
- LPTH 1996
- Fundamental
- Price
- TVRD $40.68
- LPTH $8.87
- Analyst Decision
- TVRD Strong Buy
- LPTH Strong Buy
- Analyst Count
- TVRD 5
- LPTH 3
- Target Price
- TVRD $59.20
- LPTH $6.83
- AVG Volume (30 Days)
- TVRD 67.6K
- LPTH 1.9M
- Earning Date
- TVRD 11-21-2025
- LPTH 11-06-2025
- Dividend Yield
- TVRD N/A
- LPTH N/A
- EPS Growth
- TVRD N/A
- LPTH N/A
- EPS
- TVRD N/A
- LPTH N/A
- Revenue
- TVRD N/A
- LPTH $37,202,630.00
- Revenue This Year
- TVRD N/A
- LPTH $50.36
- Revenue Next Year
- TVRD N/A
- LPTH $7.77
- P/E Ratio
- TVRD N/A
- LPTH N/A
- Revenue Growth
- TVRD N/A
- LPTH 17.26
- 52 Week Low
- TVRD $8.13
- LPTH $1.40
- 52 Week High
- TVRD $42.10
- LPTH $9.34
- Technical
- Relative Strength Index (RSI)
- TVRD 70.68
- LPTH 69.28
- Support Level
- TVRD $36.05
- LPTH $6.47
- Resistance Level
- TVRD $42.10
- LPTH $8.40
- Average True Range (ATR)
- TVRD 2.87
- LPTH 0.70
- MACD
- TVRD 0.07
- LPTH 0.06
- Stochastic Oscillator
- TVRD 82.26
- LPTH 85.46
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.